Search Results

There are 2013 results for: content related to: Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

  1. You have free access to this content
    Weight Loss, Weight Maintenance, and Improved Cardiovascular Risk Factors after 2 Years Treatment with Orlistat for Obesity

    Obesity Research

    Volume 8, Issue 1, January 2000, Pages: 49–61, Professor Stephan Rössner, Lars Sjöström, Rudolf Noack, A. Edo Meinders, Giorgio Noseda and on behalf of the European Orlistat Obesity Study

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2000.8

  2. You have free access to this content
    NPY5R Antagonism Does Not Augment the Weight Loss Efficacy of Orlistat or Sibutramine

    Obesity

    Volume 15, Issue 8, August 2007, Pages: 2027–2042, Ngozi Erondu, Carol Addy, Kaifeng Lu, Madhuja Mallick, Bret Musser, Ira Gantz, Joseph Proietto, Arne Astrup, Søren Toubro, Aila M. Rissannen, Serena Tonstad, William G. Haynes, Keith M. Gottesdiener, Keith D. Kaufman, John M. Amatruda and Steven B. Heymsfield

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2007.242

  3. Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 4, April 2009, Pages: 361–371, S. Jacob, M. Rabbia, M. K. Meier and J. Hauptman

    Version of Record online : 22 JAN 2009, DOI: 10.1111/j.1463-1326.2008.00970.x

  4. You have free access to this content
    The Safety Profiles of Orlistat and Sibutramine: Results of Prescription-Event Monitoring Studies in England

    Obesity

    Volume 15, Issue 11, November 2007, Pages: 2712–2722, Michael J. Perrio, Lynda V. Wilton and Saad A. W. Shakir

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2007.323

  5. You have free access to this content
    Orlistat 60 mg Reduces Visceral Adipose Tissue: A 24-Week Randomized, Placebo-Controlled, Multicenter Trial

    Obesity

    Volume 19, Issue 9, September 2011, Pages: 1796–1803, Steven R. Smith, Kaj S. Stenlof, Frank L. Greenway, John McHutchison, Susan M. Schwartz, Vidhu B. Dev, Evan S. Berk and Roxanne Kapikian

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2011.143

  6. Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 2, April 2012, Pages: 187–195, G. Derosa, A. F. G. Cicero, A. D’Angelo, E. Fogari and P. Maffioli

    Version of Record online : 4 AUG 2011, DOI: 10.1111/j.1365-2710.2011.01280.x

  7. Effect of antiobesity medications in patients with type 2 diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 7, July 2009, Pages: 641–664, Souzana Choussein, Angeliki A. Makri, Constantinos C. Frangos, Eleni Th. Petridou and Stella S. Daskalopoulou

    Version of Record online : 18 FEB 2009, DOI: 10.1111/j.1463-1326.2008.01026.x

  8. You have free access to this content
    Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol

    The Journal of Physiology

    Volume 577, Issue 1, November 2006, Pages: 263–280, Bela Szabo, Michal J. Urbanski, Tiziana Bisogno, Vincenzo Di Marzo, Aitziber Mendiguren, Wolfram U. Baer and Ilka Freiman

    Version of Record online : 8 NOV 2006, DOI: 10.1113/jphysiol.2006.119362

  9. Effects of Orlistat, a Lipase Inhibitor, on the Pharmacokinetics of Three Highly Lipophilic Drugs (Amiodarone, Fluoxetine, and Simvastatin) in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 43, Issue 4, April 2003, Pages: 428–435, Jianguo Zhi, Rema Moore, Linda Kanitra and Thomas E. Mulligan

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003252236

  10. You have free access to this content
    Effect of Orlistat in Obese Patients with Binge Eating Disorder

    Obesity Research

    Volume 13, Issue 10, October 2005, Pages: 1701–1708, Alain Golay, Anne Laurent-Jaccard, Frank Habicht, Jean-Pierre Gachoud, Mireille Chabloz, Anne Kammer and Yves Schutz

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2005.208

  11. You have free access to this content
    Chemical Modification and Organelle-Specific Localization of Orlistat-Like Natural-Product-Based Probes

    Chemistry – An Asian Journal

    Volume 6, Issue 10, October 4, 2011, Pages: 2762–2775, Peng-Yu Yang, Kai Liu, Chongjing Zhang, Grace Y. J. Chen, Yuan Shen, Mun Hong Ngai, Prof. Dr. Martin J. Lear and Prof. Dr. Shao Q. Yao

    Version of Record online : 8 JUL 2011, DOI: 10.1002/asia.201100306

  12. Orlistat-induced fulminant hepatic failure

    Clinical Obesity

    Volume 4, Issue 6, December 2014, Pages: 342–347, D. Sall, J. Wang, M. Rashkin, M. Welch, C. Droege and D. Schauer

    Version of Record online : 29 SEP 2014, DOI: 10.1111/cob.12075

  13. You have free access to this content
    Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting

    Obesity

    Volume 16, Issue 3, March 2008, Pages: 623–629, Susan M. Schwartz, Vidhu P. Bansal, Cecilia Hale, Maureen Rossi and Janet P. Engle

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2007.96

  14. You have free access to this content
    The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: The Swedish Multimorbidity Study

    Journal of Internal Medicine

    Volume 248, Issue 3, September 2000, Pages: 245–254, F. Lindgärde

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2796.2000.00720.x

  15. Orlistat for the treatment of obesity: rapid review and cost-effectiveness model

    Obesity Reviews

    Volume 1, Issue 2, October 2000, Pages: 121–126, D. R. Foxcroft and R. Milne

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1467-789x.2000.00011.x

  16. You have free access to this content
    Effects of Sibutramine Plus Orlistat in Obese Women Following 1 Year of Treatment by Sibutramine Alone: A Placebo-Controlled Trial

    Obesity Research

    Volume 8, Issue 6, September 2000, Pages: 431–437, Thomas A. Wadden, Robert I. Berkowitz, Leslie G. Womble, David B. Sarwer, Marjorie E. Arnold and Carrie M. Steinberg

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2000.53

  17. You have free access to this content
    Weight Loss, HbA1c Reduction, and Tolerability of Cetilistat in a Randomized, Placebo-controlled Phase 2 Trial in Obese Diabetics: Comparison With Orlistat (Xenical)

    Obesity

    Volume 18, Issue 1, January 2010, Pages: 108–115, Peter Kopelman, H. Gerrit de Groot, Aila Rissanen, Stephan Rossner, Soren Toubro, Richard Palmer, Rob Hallam, Andrew Bryson and Roger I. Hickling

    Version of Record online : 31 DEC 2012, DOI: 10.1038/oby.2009.155

  18. You have free access to this content
    Three-Month Tolerability of Orlistat in Adolescents with Obesity-Related Comorbid Conditions

    Obesity Research

    Volume 10, Issue 7, July 2002, Pages: 642–650, Jennifer R. McDuffie, Karim A. Calis, Gabriel I. Uwaifo, Nancy G. Sebring, Erica M. Fallon, Van S. Hubbard and Jack A. Yanovski

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2002.87

  19. The effect of antiobesity drugs on waist circumference: a mixed treatment comparison

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 3, March 2014, Pages: 237–247, M. Chilton, A. Dunkley, P. Carter, M. J. Davies, K. Khunti and L. J. Gray

    Version of Record online : 15 SEP 2013, DOI: 10.1111/dom.12198

  20. The effect of orlistat on the fatty acid composition of serum lipid fractions in obese subjects

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 3, September 1999, Pages: 315–322, Helvi M. Vidgren, Jyrki J. Ågren, Raisa S. Valve, Leila J. Karhunen, Aila M. Rissanen and Matti I. J. Uusitupa

    Version of Record online : 26 SEP 1999, DOI: 10.1016/S0009-9236(99)70040-8